Christopher Robinson/LinkedIn
Jul 12, 2026, 15:56
Christopher Robinson: Nipocalimab Compared With IVIG and Prednisone in FNAIT-Risk Pregnancies
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia.”
Title: Design of a Phase 3, Multicenter, Randomized, Open-Label Study of Nipocalimab or IVIG and Prednisone in Pregnancies at Risk for Fetal and Neonatal Alloimmune Thrombocytopenia
Authors: James Bussel, Barbara Stegmann, Pamela Baker, Abbie Oey, Yanxin Jiang, Rebecca Zaha, Hillary Van Valkenburgh, Babajide Keshinro
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 7, 2026, 19:12Why Does Fertility Change After 38? – Fertility Plus
-
Aug 7, 2026, 19:01Sean Lauber: Does Sex Before or After Embryo Transfer Affect Implantation or Pregnancy?
-
Aug 7, 2026, 18:53Kiani Davis: What I Would Start With in the Fertility Patient Journey
-
Aug 7, 2026, 18:41Dalia Majedi: Key Factors in Choosing an IVF Clinic Abroad
-
Aug 7, 2026, 18:32Sarah Lewen: Carousel Fertility Is Built to Help Clinics Win the Next Decade
-
Aug 7, 2026, 18:14Masoud Zamani Esteki: The Key Knowledge Gaps in Modern Ovarian Biology
-
Aug 7, 2026, 18:01Jenny Gudge: New Opportunity for a Senior Fertility Nurse in Sussex
-
Aug 7, 2026, 17:37Clare Mansfield: I Don’t Think the Future of Fertility Care is Simply More Technology
-
Aug 7, 2026, 17:30Nevena Vidakovic: Reimagining the Future of Fertility at Merck
